疱疹病毒疫苗
Herpesvirus Vaccines.
作者信息
Petrini Stefano, Maple Peter
机构信息
National Reference Centre for Infectious Bovine Rhinotracheitis (IBR), Istituto Zooprofilattico Sperimentale Umbria-Marche, Via Gaetano Salvemini 1, 06126 Perugia, Italy.
Division of Clinical Neuroscience, Section of Clinical Neurology, University of Nottingham, Nottingham NG7 2UH, UK.
出版信息
Vaccines (Basel). 2022 Apr 18;10(4):628. doi: 10.3390/vaccines10040628.
Abstract
The Special Issue titled "Herpesvirus Vaccines" contains different articles and a review regarding veterinary and human herpesviruses [...].
摘要
名为“疱疹病毒疫苗”的特刊包含了不同的文章以及一篇关于兽医和人类疱疹病毒的综述[...]。
相似文献
1
Herpesvirus Vaccines.疱疹病毒疫苗
Vaccines (Basel). 2022 Apr 18;10(4):628. doi: 10.3390/vaccines10040628.
2
Use of feline herpesvirus as a vaccine vector offers alternative applications for feline health.将猫疱疹病毒用作疫苗载体为猫科动物的健康提供了替代应用。
Vet Microbiol. 2021 Oct;261:109210. doi: 10.1016/j.vetmic.2021.109210. Epub 2021 Aug 16.
3
The glycoproteins of the human herpesviruses.人类疱疹病毒的糖蛋白
Comp Immunol Microbiol Infect Dis. 1991;14(2):81-95. doi: 10.1016/0147-9571(91)90123-u.
4
BHV-1: new molecular approaches to control a common and widespread infection.牛疱疹病毒1型：控制常见广泛感染的新分子方法
Mol Med. 1999 May;5(5):261-84.
5
Lymphomatoid papulosis and human herpesviruses--A PCR-based evaluation for the presence of human herpesvirus 6, 7 and 8 related herpesviruses.淋巴瘤样丘疹病与人类疱疹病毒——基于聚合酶链反应对人类疱疹病毒6型、7型和8型相关疱疹病毒存在情况的评估
J Cutan Pathol. 2001 Jan;28(1):29-33. doi: 10.1034/j.1600-0560.2001.280103.x.
6
Attenuated vaccines can recombine to form virulent field viruses.减毒疫苗可重组形成毒力野外病毒。
Science. 2012 Jul 13;337(6091):188. doi: 10.1126/science.1217134.
7
[Prevention and therapy of herpesvirus infections].[疱疹病毒感染的预防与治疗]
Zentralbl Bakteriol Mikrobiol Hyg B. 1985 Feb;180(2-3):107-20.
8
HERPESVIRUSES INCLUDING NOVEL GAMMAHERPESVIRUSES ARE WIDESPREAD AMONG PHOCID SEAL SPECIES IN CANADA.包括新型γ疱疹病毒在内的疱疹病毒在加拿大的海豹科海豹物种中广泛存在。
J Wildl Dis. 2016 Jan;52(1):70-81. doi: 10.7589/2015-01-020. Epub 2015 Nov 10.
9
Utilization of herpesviridae as recombinant viral vectors in vaccine development against animal pathogens.利用疱疹病毒科作为重组病毒载体在动物病原体疫苗开发中的应用。
Virus Res. 2019 Sep;270:197648. doi: 10.1016/j.virusres.2019.197648. Epub 2019 Jul 4.
10
A tale of 2 alpha-herpesviruses: lessons for vaccinologists.两种甲型疱疹病毒的故事：给疫苗学家的启示
Clin Infect Dis. 2006 Mar 15;42(6):810-7. doi: 10.1086/500141. Epub 2006 Feb 8.
本文引用的文献
1
Epstein-Barr virus and multiple sclerosis.爱泼斯坦-巴尔病毒与多发性硬化。
Science. 2022 Jan 21;375(6578):264-265. doi: 10.1126/science.abm7930. Epub 2022 Jan 13.
2
Infections at the maternal-fetal interface: an overview of pathogenesis and defence.母胎界面感染：发病机制与防御概述。
Nat Rev Microbiol. 2022 Feb;20(2):67-82. doi: 10.1038/s41579-021-00610-y. Epub 2021 Aug 25.
3
Evaluation of Safety and Efficacy of an Inactivated Marker Vaccine against (BoHV-1) in Water Buffalo ().一种针对水牛（）的抗牛疱疹病毒1型（BoHV-1）灭活标记疫苗的安全性和有效性评估。
Vaccines (Basel). 2021 Apr 7;9(4):355. doi: 10.3390/vaccines9040355.
4
Evaluation of Three Different Vaccination Protocols against EHV1/EHV4 Infection in Mares: Double Blind, Randomized Clinical Trial.针对母马感染马疱疹病毒1型/4型的三种不同疫苗接种方案的评估：双盲随机临床试验
Vaccines (Basel). 2020 Jun 1;8(2):268. doi: 10.3390/vaccines8020268.
5
Immunization with Human Cytomegalovirus Core Fusion Machinery and Accessory Envelope Proteins Elicit Strong Synergistic Neutralizing Activities.用人巨细胞病毒核心融合机制和辅助包膜蛋白进行免疫可引发强烈的协同中和活性。
Vaccines (Basel). 2020 Apr 13;8(2):179. doi: 10.3390/vaccines8020179.
6
The Status of Vaccine Development Against the Human Cytomegalovirus.人类巨细胞病毒疫苗的研发现状。
J Infect Dis. 2020 Mar 5;221(Suppl 1):S113-S122. doi: 10.1093/infdis/jiz447.
7
Cytomegalovirus and Epstein-Barr Virus Associations with Neurological Diseases and the Need for Vaccine Development.巨细胞病毒和爱泼斯坦-巴尔病毒与神经系统疾病的关联及疫苗研发需求
Vaccines (Basel). 2020 Jan 20;8(1):35. doi: 10.3390/vaccines8010035.
8
Evaluation of Passive Immunity Induced by Immunisation Using Two Inactivated gE-deleted Marker Vaccines against Infectious Bovine Rhinotracheitis (IBR) in Calves.使用两种针对犊牛传染性牛鼻气管炎（IBR）的灭活gE缺失标记疫苗免疫诱导的被动免疫评估。
Vaccines (Basel). 2020 Jan 4;8(1):14. doi: 10.3390/vaccines8010014.
9
Simultaneous Deletion of Virulence Factors and Insertion of Antigens into the Infectious Laryngotracheitis Virus Using NHEJ-CRISPR/Cas9 and Cre-Lox System for Construction of a Stable Vaccine Vector.利用非同源末端连接-CRISPR/Cas9和Cre-Lox系统同时删除毒力因子并将抗原插入传染性喉气管炎病毒以构建稳定疫苗载体
Vaccines (Basel). 2019 Dec 5;7(4):207. doi: 10.3390/vaccines7040207.
10
Changes to virus taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2019).病毒分类学和国际病毒分类与命名法规的变更，经国际病毒分类委员会批准（2019 年）。
Arch Virol. 2019 Sep;164(9):2417-2429. doi: 10.1007/s00705-019-04306-w.
Zotero 插件